Tc. Tai et al., Role of Egr-1 in cAMP-dependent protein kinase regulation of the phenylethanolamine N-methyltransferase gene, J NEUROCHEM, 76(6), 2001, pp. 1851-1859
The molecular mechanism by which cAMP activates the rat phenylethanolamine
N-methyltransferase (PNMT) gene was examined by transient transfection of t
he wild-type rat PNMT promoter-luciferase reporter gene construct pGL3RP893
into PC12 cells. Forskolin treatment (10 muM) of the transfected cells for
3-6 h maximally induced luciferase threefold. Induction by forskolin was m
imicked by the cAMP analog, 8-Br-cAMP, and prevented in PC12 cells pretreat
ed with the protein kinase A (PKA) inhibitor H-89 or co-transfected with an
expression construct for PKI, a polypeptide inhibitor of PKA. Furthermore,
forskolin did not activate the PNMT promoter when the 893 bp PNMT promoter
-reporter gene construct was transfected into the PKA-deficient cell line.
A126. Detailed examination of the forskolin responsiveness of PNMT construc
ts harboring greater than or equal to 60 bp and < 893 bp of PNMT promoter d
emonstrated that the cAMP-responsive element(s) lay between < 392 bp and gr
eater than or equal to 60 bp. Within this region of the promoter lies a fun
ctional binding element for Egr-1, a transcriptional activator of the PNMT
gene. Forskolin treatment of PC12 cells also rapidly increased nuclear leve
ls of Egr-1 and the catalytic subunit of PKA (PKA-C), with the rise in PKA-
C preceding that of Egr-1. Mutation of the -165 bp Egr-1 site markedly decr
eased forskolin activation of the PNMT promoter. These findings demonstrate
that the rat PNMT gene promoter can be activated via the cAMP-PKA signal t
ransduction pathway, mediated by the immediate early gene transcription fac
tor, Egr-1.